Disruption of thiol homeostasis in plasma of terminal renal failure patients

Clinica Chimica Acta

Volumn 366, Issue 1-2, 2006, Pages 137-145

  Włodek, Przemysław J ^a   Smolenski, Olgierd B ^a   Chwatko, Grazyna ^c   Iciek, Małgorzata B ^b   Miłkowski, Andrzej ^a   Bald, Edward ^c   Włodek, Lidia ^b  

^a Ludwik Rydygier Speciality Hospital in Krakow   (Poland)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^c UNIVERSITY OF LODZ   (Poland)

Author keywords

Cysteine; Cysteinylglycine; Glutathione; Homocysteine; Mixed disulfides; Terminal renal failure

Indexed keywords

CYSTEINE; DISULFIDE; HOMOCYSTEINE; THIOL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEMODIALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOMEOSTASIS; HUMAN; KIDNEY FAILURE; MALE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYSTEINE; FEMALE; GLUTATHIONE; HOMEOSTASIS; HOMOCYSTEINE; HUMANS; KIDNEY FAILURE; MALE; MIDDLE AGED; RENAL DIALYSIS; SPECTROPHOTOMETRY, ULTRAVIOLET; SULFHYDRYL COMPOUNDS; TIME FACTORS;

EID: 33644680130     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2005.09.028     Document Type: Article

References (47)

1. J. Choi, R.M. Liu, and R.K. Kundu Molecular mechanism of decreased glutathione content in human immunodeficiency virus type 1 Tat-transgenic mice J Biol Chem 275 2000 3693 3698
2. J. Sian, D.T. Dexter, and A.J. Lees Alteration of glutathione levels in Parkinson's desease and other neurodegenerative disorders affecting basal ganglia Ann Neurol 36 1994 348 355
3. P.S. Samiec, C. Drews-Botsch, and E.W. Flagg Glutathione in human plasma: decline in association with aging, age-related macular degeneration and diabetes Free Radic Biol Med 24 1998 699 704
4. C.A. Lang, S. Naryshkin, D.L. Schneider, B.J. Mills, and R.D. Lindeman Low blood glutathione levels in healthy aging adults J Lab Clin Med 120 1992 720 725
5. M. Iciek, and L. Włodek Biosynthesis and biological properties of compounds containing highly reactive reduced sulfane sulfur Pol J Pharmacol 53 2001 215 225
6. K.S. McCully Homocysteine and vascular disease Nat Med 2 1996 386 389
7. P.M. Ueland Homocysteine species as components of plasma redox thiol status Clin Chem 41 1995 340 342
8. P.M. Ueland, M.A. Mansoor, and A.B. Guttormsen Reduced, oxidized and protein-bound forms of homocysteine and other aminothiols in plasma comprise the redox thiol status-a possible element of the extracellular antioxidant defense system J Nutr 126 1996 1281S 1284S
9. A. Andersson, A. Lindgren, M. Arnadottir, H. Prytz, and B. Hultberg Thiols as a measure of plasma redox status in healthy subjects and in patients with renal or liver failure Clin Chem 45 1999 1084 1086
10. A.G. Bostom, and B.F. Culleton Hyperhomocysteinemia in chronic renal disease J Am Soc Nephrol 10 1999 891 900
11. E. Bald, and R. Głowacki 2-Chloro-1-methylquinolinium tetrafluoroborate as an effective and thiol specific UV-tagging reagent for liquid chromatography J Liq Chromatogr Relat Technol 24 2001 1323 1339
12. E. Bald, G. Chwatko, R. Głowacki, and K. Kuśmierek Analysis of plasma thiols by high-performance liquid chromatography with ultraviolet detection J Chromatogr A 1032 2004 109 115
13. W. Siems, S. Quast, and F. Carluccio Oxidative stress in chronic renal failure as a cardiovascular risk factor Clin Nephrol 58 2002 S12 S19
14. R.N. Foley, P.S. Parfrey, and M.J. Sarnak Clinical epidemiology of cardiovascular disease in chronic renal disease Am J Kidney Dis 32 Suppl. 3 1998 S112 S119
15. E. Bald, G. Chwatko, and J. Drzewoski Extracellular thiol redox status evaluation by high performance liquid chromatography detection Int Symp on high performance liquid phase separations and related techniques (HPLC-Kyoto) Japan chromatography vol. 22 2001 191
16. W.A. Kleinman, and J.P. Richie Jr. Status of glutathione and other thiols and disulfides in human plasma Biochem Pharmacol 60 2000 19 29
17. M.A. Mansoor, A.M. Svardal, and P.M. Ueland Determination of the in vivo redox status of cysteine, cysteinylglycine, homocysteine and glutathione in human plasma Anal Biochem 200 1992 218 229
18. T. Nguyen-Khoa, Z.A. Massy, and J.P. De Bandt Oxidative stress and haemodialysis: role of inflamation and duration of dialysis treatment Nephrol Dial Transplant 16 2001 335 340
19. J.P. Włodek, M.B. Iciek, A. Miłkowski, and O.B. Smoleński Various forms of plasma cysteine and its metabolites in patients undergoing hemodialysis Clin Chim Acta 304 2001 9 19
20. B.J. Mills, M.M. Weiss, C.A. Long, M.C. Liu, and C. Ziegler Blood glutathione and cysteine changes in cardiovascular disease J Lab Clin Med 135 2000 396 401
21. A.B. Guttormsen, P.M. Ueland, E. Svarstad, and H. Refsum Kinetic basis of hyperhomocysteinemia in patients with chronic renal failure Kidney Int 52 1997 495 502
22. P. Chauveau, B. Chadefaux, and M. Coude Hyperhomocysteinemia, a risk factor for artherosclerosis in chronic uremic patients Kidney Int 41 Suppl. 43 1993 S72 S77
23. A. Tizianello, G. De Ferrari, G. Garibotto, G. Gurreri, and C. Robaudo Renal metabolism of amino acids and ammonia in subjects with normal renal function and in patients with chronic renal insufficiency J Clin Invest 65 1980 1162 1173
24. W. Druml, M. Fischer, B. Liebish, K. Lenz, and E. Roth Elimination of amino acids in renal failure Am J Clin Nutr 60 1994 418 423
25. P. Klatt, and S. Lamas Regulation of protein function by S-glutathiolation in response to oxidative and nitrosative stress Eur J Biochem 267 2000 4928 4944
26. M.A. Mansoor, P.M. Ueland, A. Aarsland, and A.M. Svardal Redox status and protein binding of plasma homocysteine and other aminothiols in patient with homocystynuria Metabolism 42 1993 1481 1485
27. S. Sengupta, H. Chen, and T. Togawa Albumin thiolate anion is an intermediate in the formation of albumin-S-S-homocysteine J Biol Chem 276 2001 30111 30117
28. P. Wardman Reactions of thiyl radicals L. Packer E. Cadenas Biothiols in health and disease 1995 Marcel Dekker New York 1 19
29. R.T. Wall, J.M. Harlan, L.A. Harker, and G.E. Striker Homocysteine-induced endothelial cell injury in vitro: a model for the study of vascular injury Thromb Res 18 1980 113 121
30. A.F. Perna, D. Ingrosso, and C. Lombardi Possible mechanisms of homocysteine toxicity Kidney Int Suppl 84 2003 S137 S140
31. J.S. Stamler, J.A. Osborne, and O. Jaraki Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen J Clin Invest 91 1993 308 318
32. P. Muniz, P. Saez, A. Iradi, J. Vina, M.R. Oliva, and G.T. Saez Differences between cysteine and homocysteine in the induction of deoxyribose degradation and DNA damage Free Radic Biol Med 30 2001 354 362
33. S. Parthasarathy Oxidation of low-density lipoprotein by thiol compounds leads to its recognition by the acetyl-LDL receptor Biochim Biophys Acta 917 1987 337 340
34. S. Sengupta, C. Wehbe, A.K. Majors, M.E. Ketterer, P.M. Di Bello, and D.W. Jacobsen Relative roles of albumin and ceruloplasmin in the formation of homocystine, homocysteine - cysteine mixed disilfide and cystine in circulation J Biol Chem 276 2001 46896 46904
35. H. Jakubowski Protein N-homocysteinylation: implications for atherosclerosis Biomed Pharmacother 55 2001 443 447
36. S. Sengupta, H. Chen, and T. Togawa Albumin thiolate anion is an intermediate in the formation of albumin-S-S-homocysteine J Biol Chem 276 2001 30111 30117
37. D. Giuseppe, S. Frosali, and R. Priora The effects of age and hyperhomocysteinemia on the redox forms of plasma thiols J Lab Clin Med. 144 2004 235 245
38. N.P. Dudman An alternative view of homocysteine Lancet 354 1999 2072 2074
39. ras methylation in vascular endothelial cells by homocysteine but not cysteine J Biol Chem 272 1997 24380 25385
40. D. Giuseppe, P. Di Simplicio, P.L. Capecchi, P.E. Lazzerini, and F.L. Pasini Alteration in the redox state of plasma in heart-transplant patients with moderate hyperhomocysteinemia J Lab Clin Med 142 2003 21 28
41. M.H. Stipanuk, M. Londono, J.I. Lee, M. Hu, and A.F. Yu Enzymes and metabolites of cysteine metabolism in nonhepatic tissues of rats show little response to changes in dietary protein or sulfur aminoacid levels J Nutr 132 2002 3369 3378
42. J.P. Włodek, J. Kucharczyk, and M.M. Sokołowska Alteration in plasma levels of nonprotein sulfhydryl compounds and S-nitrosothiols in chronic renal failure patients Clin Chim Acta 327 2003 87 94
43. M. Satoh, Y. Yamasaki, and Y. Nagake Oxidative stress is reduced by the long-term use witamin E-coated dialysis filters Kidney Int 59 2001 1943 1950
44. O. Sommerburg, T. Grüne, and H. Hampl Does long term treatment of renal anaemia with recombinant erythropoietin influence oxidative stress in haemodialysed patients? Nephrol Dial Transplant 13 1998 2583 2587
45. M. Tepel, M. van der Giet, M. Statz, J. Jankowski, and W. Zidek The antioxidant acetylcysteine reduces cardiovascular events in patients with end-stage renal failure: a randomized, controlled trial Circulation 107 2003 992 995
46. E. Mervaala, P. Finckenberg, and R. Lapatto Lipoic acid supplementation prevents angiotensin II-induced renal injury Kidney Int 64 2003 501 508
47. M. Usberti, G. Lima, M. Arisi, G. Bufano, L. D'Avanzo, and R.M. Gazzotti Effect of exogenous reduced glutathione on the survival of red blood cells in hemodialyzed patients J Nephrol 10 1997 261 265